What Advancements Have Been Made in Anticoagulation Management in Special Populations?

 

At the ISTH 2020 Virtual Congress, thousands of the world’s leading experts on thrombosis, hemostasis and vascular biology came together to present the most recent advances, exchange the latest science and discuss the newest clinical applications designed to improve patient care.

Through an extensive lineup of educational sessions, poster and oral communications, state-of-the-art lectures, medical industry exhibits and professional networking opportunities, the Congress promoted important scientific discourse and advancement, especially within the field of thrombosis.

Dr. Beverley Hunt, Dr. Alexander Cohen, and Prof. Saskia Middeldorp discussed advancements that have been made in special populations related to anticoagulation management.

Previous Article Is Anticoagulation Reversal Needed/Warranted with Latest Data?
Next Article What are the 3-4 Major Findings from the 2020 Virtual Meeting?
Print

Theme picker